- Report
- April 2025
- 200 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- February 2025
- 200 Pages
Global
From €3920EUR$4,490USD£3,394GBP
- Report
- July 2025
- 185 Pages
Global
From €3929EUR$4,500USD£3,402GBP
- Report
- February 2026
- 340 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 369 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 497 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 389 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 380 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 192 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 274 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 473 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 378 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 196 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- February 2026
- 510 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 120 Pages
Global
From €4147EUR$4,750USD£3,591GBP
- Report
- May 2025
- 110 Pages
Global
From €4147EUR$4,750USD£3,591GBP
- Report
- June 2025
- 400 Pages
Global
From €4321EUR$4,949USD£3,741GBP
- Report
- July 2025
- 257 Pages
Global
From €4361EUR$4,995USD£3,776GBP
- Report
- November 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,910GBP
€4235EUR$4,850USD£3,666GBP
- Report
- September 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,910GBP
€4235EUR$4,850USD£3,666GBP

Alzheimer's Disease is a neurological disorder that affects memory, thinking, and behavior. It is the most common form of dementia, a group of disorders that cause a decline in cognitive function. Symptoms of Alzheimer's Disease include memory loss, difficulty with problem-solving, and changes in behavior. As the disease progresses, individuals may experience difficulty with language, disorientation, and difficulty with daily activities.
The Alzheimer's Disease market is a subset of the larger Neurology market. It is a rapidly growing market, driven by an aging population and increased awareness of the disease. Companies in the market are focused on developing treatments and therapies to improve the quality of life for those affected by the disease.
Companies in the Alzheimer's Disease market include Biogen, Eli Lilly, Novartis, and Roche. Other companies in the market include AbbVie, AstraZeneca, Merck, and Pfizer. Show Less Read more